Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Operating Expenses | 15,598 | 13,789 | 9,986 | 7,449 | 3,230 |
| Operating Income | -15,598 | -13,789 | -9,986 | -7,449 | -3,230 |
| Interest Expense | 16 | 16 | 851 | 9 | 8 |
| Other Income | 53 | 1,268 | 452 | -837 | 335 |
| Pre-tax Income | -15,562 | -12,537 | -10,385 | -8,296 | -2,902 |
| Net Income Continuous | -15,562 | -12,537 | -10,385 | -8,296 | -2,902 |
| Net Income | $-15,562 | $-12,537 | $-10,385 | $-8,296 | $-2,902 |
| EPS Basic Total Ops | -19.25 | -29.25 | -47.25 | -57.25 | -34.25 |
| EPS Basic Continuous Ops | -19.30 | -29.20 | -47.36 | -57.24 | -34.19 |
| EPS Diluted Total Ops | -19.25 | -29.25 | -47.25 | -57.25 | -34.25 |
| EPS Diluted Continuous Ops | -19.30 | -29.20 | -47.36 | -57.24 | -34.19 |
| EBITDA(a) | $-15,598 | $-13,787 | $-9,984 | $-7,448 | $-3,230 |